Gene: AVPI1
Official Full Name: arginine vasopressin induced 1provided by HGNC
Gene Summary: Predicted to be involved in positive regulation of MAPK cascade. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19517 | AVPI1 Knockout cell line (HeLa) | Human | AVPI1 | 1:3~1:6 | Negative | Online Inquiry |
KO19518 | AVPI1 Knockout cell line (HCT 116) | Human | AVPI1 | 1:2~1:4 | Negative | Online Inquiry |
KO19519 | AVPI1 Knockout cell line (HEK293) | Human | AVPI1 | 1:3~1:6 | Negative | Online Inquiry |
KO19520 | AVPI1 Knockout cell line (A549) | Human | AVPI1 | 1:3~1:4 | Negative | Online Inquiry |
AVPI1 Gene Knockout Cell Lines are advanced biological tools specifically designed for functional genomics studies. These cell lines have been engineered through precise gene-editing techniques, such as CRISPR-Cas9, to create knockout models where the AVPI1 gene has been inactivated. This allows researchers to investigate the role of the AVPI1 gene in various cellular processes, such as proliferation, differentiation, and response to stimuli, by providing a controlled environment where the gene's function is completely abolished.
The key mechanism underlying the AVPI1 gene knockout is the specific targeting and disruption of the AVPI1 gene sequence, leading to a loss of function. This offers a unique opportunity to assess the phenotypic consequences of AVPI1 deficiency in both in vitro and in vivo models. The cell lines can be employed in numerous research applications, including cancer biology, developmental studies, and drug discovery, thereby elucidating pathways and identifying therapeutic targets that can enhance treatment strategies.
In clinical and research settings, the AVPI1 Gene Knockout Cell Lines stand out due to their reliability and reproducibility. They provide a more accurate model compared to traditional RNA interference methods, which often result in incomplete gene silencing. This specificity minimizes off-target effects and enables clearer interpretations of experimental results, thus accelerating the pace of scientific discovery.
Researchers and clinicians will find the AVPI1 Gene Knockout Cell Lines valuable for their potential to unravel the complexities of gene function and regulatory networks, ultimately driving innovation in therapeutic development. These tools not only empower users to explore fundamental biological questions but also facilitate the transition from bench to bedside.
With a commitment to excellence, our company leverages cutting-edge biotechnology and extensive expertise in genetic engineering to offer premium products that meet the highest standards for scientific investigation. Our dedication to supporting the research community drives us to provide robust and innovative tools like the AVPI1 Gene Knockout Cell Lines, ensuring that we remain at the forefront of advancing life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.